Innate Pharma S.A. (IPHA) Q2 2024 Earnings Call Transcript
…
1,747€
1,75%
Echtzeit-Aktienkurs Innate Pharma S.A.
Bid:
Ask:
Nachrichten zur Innate Pharma S.A. Aktie
Global Hematologic Malignancies Market Size To Worth USD 144.58 Billion By 2033 | CAGR Of 7.97%
The Global Hematologic Malignancies Market Size was Valued at USD 67.18 Billion in 2023 and the Worldwide Hematologic Malignancies Market…
Innate Pharma S.A. (IPHA) Q1 2024 Earnings Call Transcript
…
Sezary Syndrome Pipeline Insights 2024, Featuring Major Players 4SC, Seagen, Merck Sharp & Dohme, Innate Pharma, Trillium Therapeutics and Secura Bio
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Sezary Syndrome - Pipeline Insights, 2024" has been added to…
Innate Pharma S.A. (IPHA) Q4 2023 Earnings Call Transcript
…